Back to search

Wild Bioscience Ltd

13355116

active
ltd
england wales
Companies House
Health Score
85 / 100

Healthy

25/30
Filing
20/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)

Details

115k Olympic Avenue 115k Olympic Avenue, Milton Park, Abingdon, OX14 4SA
Incorporated 23/04/2021

Compliance

Last accounts

30/04/2025

small

Next accounts due

31/12/2026

On track

Confirmation statement

Last: 22/04/2026

Due 06/05/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Ross-William Stephen Hendron

director · Since 23/04/2021

Irish · England

Dr Ross-William Stephen Hendron

director · Since 23/04/2021

ENTREPRENEUR IN RESIDENCE

IRISH · ENGLAND

Professor Steven Bryan Kelly

director · Since 23/04/2021

ASSOCIATE PROFESSOR

IRISH · UNITED KINGDOM

Also on 1 other board

Steven Bryan Kelly

director · Since 23/04/2021

Irish · United Kingdom

Martin Guy Fiennes

director · Since 27/07/2021

British · England

Mr Martin Guy Fiennes

director · Since 27/07/2021

COMPANY DIRECTOR

BRITISH · ENGLAND

Also on 5 other boards

Charles David Nicholson

director · Since 22/09/2022

British,American · United States

Dr Charles David Nicholson

director · Since 22/09/2022

SCIENTIST, BOARD MEMBER

BRITISH,AMERICAN · UNITED STATES

Lisa Michelle Flashner

director · Since 14/10/2025

American · United Kingdom

Ms Lisa Michelle Flashner

director · Since 14/10/2025

DIRECTOR

AMERICAN · UNITED KINGDOM

Former

Andre Crawford-Brunt

director · Resigned 14/10/2025

Persons with Significant Control

Oxford Science Enterprises Holdings Ii Limited

25–50% shares
25–50% votes

Reg: 16279473 · Companies House · Private Limited Company

Notified 31/03/2025

Lawrence Ellison

ownership-of-shares-25-to-50-percent-as-trust
voting-rights-25-to-50-percent-as-trust

American · United States

Notified 14/10/2025

Mr Paul Timothy Marinelli

ownership-of-shares-25-to-50-percent-as-trust
voting-rights-25-to-50-percent-as-trust

American · United States

Notified 14/10/2025

Mr Lawrence Joseph Ellison

ownership-of-shares-25-to-50-percent-as-trust
voting-rights-25-to-50-percent-as-trust

American · United States

Notified 14/10/2025

Former PSCs

Dr Ross-William Stephen Hendron

Ceased 28/07/2021

Dr Steven Bryan Kelly

Ceased 28/07/2021

Oxford Science Enterprises Plc

Ceased 31/03/2025

Dr Steven Bryan Kelly

Ceased 23/12/2022

Change History

status → active
2026-07-29

Active

type → ltd
2026-07-29

Private Limited Company

address line1 → 115k Olympic Avenue 115k Olympic Avenue
2026-07-29

115K OLYMPIC AVENUE 115K OLYMPIC AVENUE

post town → Abingdon
2026-07-29

ABINGDON

officer appointed → FIENNES, Martin Guy
2026-07-29
officer appointed → FLASHNER, Lisa Michelle
2026-07-29
officer appointed → HENDRON, Ross-William Stephen, Dr
2026-07-29
officer appointed → KELLY, Steven Bryan, Professor
2026-07-29
officer appointed → NICHOLSON, Charles David, Dr
2026-07-29

CompanyRankvs 233+ SIC 72110 peers
80

Financial strength95th percentile among SIC peers · 24/25
Employees98th percentile among SIC peers · 15/15
LiquidityCurrent ratio 12.07× · 20/20
Longevity6 years trading (max 15) · 6/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity6/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/04/2025

Net Worth

£2.0M

Balance sheet strength

Cash

£6.6M

Cash in the bank

Net Current Assets

£7.0M

Working capital

Current Assets

£7.6M

Current Liabilities

£631k

Fixed Assets

£2.5M

Debtors

£984k

Profit After Tax

-£4.5M

27avg. employees+13

People Costs

Wages & salaries£1.5M
NI contributions£159k

Balance Sheet

Bank loans & overdrafts£7.4M
Assets less current liabilities£9.5M
Prepared with Caseware UK (AP4) 2024.0.164

EstimatesDerived

YearCurrent Ratio
202512.07
202329.49

Derived from filed accounts. Not audited figures.